| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Microbiology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
2 Division of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
Correspondence
Hak Hotta
hotta{at}kobe-u.ac.jp
The non-structural protein 5A (NS5A) of hepatitis C virus (HCV) has been implicated in inhibition of antiviral activity of IFN. While previous studies have suggested an interaction between NS5A and the double-stranded RNA-dependent protein kinase (PKR), the possibility still remains that interaction with another molecule(s) is involved in the NS5A-mediated inhibition of IFN. In the present study, we investigated a possible interaction between NS5A and 2',5'-oligoadenylate synthetase (2-5AS), another key molecule in antiviral activity. We observed that NS5A physically interacted with 2-5AS in cultured cells, with an N-terminal portion of NS5A [aa 1–148; NS5A(1–148)] and two separate portions of 2-5AS (aa 52–104 and 184–275) being involved in the interaction. Single point mutations at residue 37 of NS5A affected the degree of the interaction with 2-5AS, with a Phe-to-Leu mutation (F37L) augmenting and a Phe-to-Asn mutation (F37N) diminishing it. Virus rescue assay revealed that the full-length NS5A (NS5A-F) and NS5A(1–148), the latter of which contains neither the IFN sensitivity-determining region (ISDR) nor the PKR-binding domain, significantly counteracted the antiviral activity of IFN. Introduction of a F37N mutation into NS5A(1–148) impaired the otherwise more significant IFN-inhibitory activity of NS5A(1–148). It was also found that the F37N mutation was highly disadvantageous for the replication of an HCV RNA replicon. Taken together, our results suggest the possibility that NS5A interacts with 2-5AS and inhibits the antiviral activity of IFN in an ISDR-independent manner.
This article has been cited by other articles:
|
|
 |
|
  S. Inubushi, M. Nagano-Fujii, K. Kitayama, M. Tanaka, C. An, H. Yokozaki, H. Yamamura, H. Nuriya, M. Kohara, K. Sada, et al. Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk J. Gen. Virol., May 1, 2008; 89(5): 1231 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Abe, Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. Takeuchi, T. Kawai, T. Kanto, et al. Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines J. Virol., September 1, 2007; 81(17): 8953 - 8966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wohnsland, W. P. Hofmann, and C. Sarrazin Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Clin. Microbiol. Rev., January 1, 2007; 20(1): 23 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nomura-Takigawa, M. Nagano-Fujii, L. Deng, S. Kitazawa, S. Ishido, K. Sada, and H. Hotta Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis J. Gen. Virol., July 1, 2006; 87(7): 1935 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Deng, M. Nagano-Fujii, M. Tanaka, Y. Nomura-Takigawa, M. Ikeda, N. Kato, K. Sada, and H. Hotta NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner J. Gen. Virol., June 1, 2006; 87(6): 1703 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kalamvoki, U. Georgopoulou, and P. Mavromara The NS5A Protein of the Hepatitis C Virus Genotype 1a Is Cleaved by Caspases to Produce C-terminal-truncated Forms of the Protein That Reside Mainly in the Cytosol J. Biol. Chem., May 12, 2006; 281(19): 13449 - 13462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kajaste-Rudnitski, T. Mashimo, M.-P. Frenkiel, J.-L. Guenet, M. Lucas, and P. Despres The 2',5'-Oligoadenylate Synthetase 1b Is a Potent Inhibitor of West Nile Virus Replication Inside Infected Cells J. Biol. Chem., February 24, 2006; 281(8): 4624 - 4637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Windisch, M. Frese, A. Kaul, M. Trippler, V. Lohmann, and R. Bartenschlager Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line J. Virol., November 1, 2005; 79(21): 13778 - 13793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hidajat, M. Nagano-Fujii, L. Deng, M. Tanaka, Y. Takigawa, S. Kitazawa, and H. Hotta Hepatitis C virus NS3 protein interacts with ELKS-{delta} and ELKS-{alpha}, members of a novel protein family involved in intracellular transport and secretory pathways J. Gen. Virol., August 1, 2005; 86(8): 2197 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jones, A. Davidson, L. Hibbert, P. Gruenwald, J. Schlaak, S. Ball, G. R. Foster, and M. Jacobs Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression J. Virol., May 1, 2005; 79(9): 5414 - 5420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Pfeiffer and K. Kirkegaard Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNA J. Virol., February 15, 2005; 79(4): 2346 - 2355. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
